379 related articles for article (PubMed ID: 32560408)
1. Cancer Immunotherapeutic Potential of NKTT320, a Novel, Invariant, Natural Killer T Cell-Activating, Humanized Monoclonal Antibody.
Patel NP; Guan P; Bahal D; Hashem T; Scheuplein F; Schaub R; Nichols KE; Das R
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560408
[TBL] [Abstract][Full Text] [Related]
2. Combination of NKT14m and Low Dose IL-12 Promotes Invariant Natural Killer T Cell IFN-γ Production and Tumor Control.
Guan P; Schaub R; Nichols KE; Das R
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708464
[TBL] [Abstract][Full Text] [Related]
3. T Cell Receptor-Engaging Monoclonal Antibodies Mobilize the Anti-Tumor Functions of Invariant Natural Killer T Cells.
Das R
Crit Rev Oncog; 2024; 29(1):69-81. PubMed ID: 38421715
[TBL] [Abstract][Full Text] [Related]
4. Activated invariant natural killer T cells directly recognize leukemia cells in a CD1d-independent manner.
Aoki T; Takami M; Takatani T; Motoyoshi K; Ishii A; Hara A; Toyoda T; Okada R; Hino M; Koyama-Nasu R; Kiuchi M; Hirahara K; Kimura MY; Nakayama T; Shimojo N; Motohashi S
Cancer Sci; 2020 Jul; 111(7):2223-2233. PubMed ID: 32324315
[TBL] [Abstract][Full Text] [Related]
5. West Nile virus-infected human dendritic cells fail to fully activate invariant natural killer T cells.
Kovats S; Turner S; Simmons A; Powe T; Chakravarty E; Alberola-Ila J
Clin Exp Immunol; 2016 Nov; 186(2):214-226. PubMed ID: 27513522
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory potential of
Bond NG; Fahlberg MD; Yu S; Rout N; Tran D; Fitzpatrick-Schmidt T; Sprehe LM; Scheef EA; Mudd JC; Schaub R; Kaur A
iScience; 2022 Mar; 25(3):103889. PubMed ID: 35243248
[TBL] [Abstract][Full Text] [Related]
7. Human invariant NKT cell subsets differentially promote differentiation, antibody production, and T cell stimulation by B cells in vitro.
Zeng SG; Ghnewa YG; O'Reilly VP; Lyons VG; Atzberger A; Hogan AE; Exley MA; Doherty DG
J Immunol; 2013 Aug; 191(4):1666-76. PubMed ID: 23851681
[TBL] [Abstract][Full Text] [Related]
8. Serial Stimulation of Invariant Natural Killer T Cells with Covalently Stabilized Bispecific T-cell Engagers Generates Antitumor Immunity While Avoiding Anergy.
Kharkwal SS; Johndrow CT; Veerapen N; Kharkwal H; Saavedra-Avila NA; Carreño LJ; Rothberg S; Zhang J; Garforth SJ; Jervis PJ; Zhang L; Donda A; Besra AK; Cox LR; Almo SC; Howell A; Evans EE; Zauderer M; Besra GS; Porcelli SA
Cancer Res; 2021 Apr; 81(7):1788-1801. PubMed ID: 33483371
[TBL] [Abstract][Full Text] [Related]
9. IL-7 During Antigenic Stimulation Using Allogeneic Dendritic Cells Promotes Expansion of CD45RA
Trujillo-Ocampo A; Cho HW; Clowers M; Pareek S; Ruiz-Vazquez W; Lee SE; Im JS
Front Immunol; 2020; 11():567406. PubMed ID: 33329531
[TBL] [Abstract][Full Text] [Related]
10. CD1d-independent activation of invariant natural killer T cells by staphylococcal enterotoxin B through major histocompatibility complex class II/T cell receptor interaction results in acute lung injury.
Rieder SA; Nagarkatti P; Nagarkatti M
Infect Immun; 2011 Aug; 79(8):3141-8. PubMed ID: 21628519
[TBL] [Abstract][Full Text] [Related]
11. Enhancing the antitumor functions of invariant natural killer T cells using a soluble CD1d-CD19 fusion protein.
Das R; Guan P; Wiener SJ; Patel NP; Gohl TG; Evans E; Zauderer M; Nichols KE
Blood Adv; 2019 Mar; 3(5):813-824. PubMed ID: 30858151
[TBL] [Abstract][Full Text] [Related]
12. Antibody-dependent cellular cytotoxicity toward neuroblastoma enhanced by activated invariant natural killer T cells.
Mise N; Takami M; Suzuki A; Kamata T; Harada K; Hishiki T; Saito T; Terui K; Mitsunaga T; Nakata M; Ikeuchi T; Nakayama T; Yoshida H; Motohashi S
Cancer Sci; 2016 Mar; 107(3):233-41. PubMed ID: 26749374
[TBL] [Abstract][Full Text] [Related]
13. Functions of CD1d-Restricted Invariant Natural Killer T Cells in Antimicrobial Immunity and Potential Applications for Infection Control.
Kinjo Y; Takatsuka S; Kitano N; Kawakubo S; Abe M; Ueno K; Miyazaki Y
Front Immunol; 2018; 9():1266. PubMed ID: 29928278
[TBL] [Abstract][Full Text] [Related]
14. Exploiting the CD1d-iNKT cell axis for potentiation of DC-based cancer vaccines.
Lameris R; Schneiders FL; de Gruijl TD; van der Vliet HJ
Methods Mol Biol; 2014; 1139():155-65. PubMed ID: 24619678
[TBL] [Abstract][Full Text] [Related]
15. A humanized monoclonal antibody specific for invariant Natural Killer T (iNKT) cells for in vivo depletion.
Scheuplein F; Thariath A; Macdonald S; Truneh A; Mashal R; Schaub R
PLoS One; 2013; 8(9):e76692. PubMed ID: 24086759
[TBL] [Abstract][Full Text] [Related]
16. Characterization and Functional Analysis of Mouse Semi-invariant Natural T Cells.
Kumar A; Bezbradica JS; Stanic AK; Joyce S
Curr Protoc Immunol; 2017 Apr; 117():14.13.1-14.13.55. PubMed ID: 28369682
[TBL] [Abstract][Full Text] [Related]
17. Significance of Frequencies, Compositions, and/or Antileukemic Activity of (DC-stimulated) Invariant NKT, NK and CIK Cells on the Outcome of Patients With AML, ALL and CLL.
Boeck CL; Amberger DC; Doraneh-Gard F; Sutanto W; Guenther T; Schmohl J; Schuster F; Salih H; Babor F; Borkhardt A; Schmetzer H
J Immunother; 2017; 40(6):224-248. PubMed ID: 28557814
[TBL] [Abstract][Full Text] [Related]
18. Early activation of invariant natural killer T cells in a rheumatoid arthritis model and application to disease treatment.
Miellot-Gafsou A; Biton J; Bourgeois E; Herbelin A; Boissier MC; Bessis N
Immunology; 2010 Jun; 130(2):296-306. PubMed ID: 20113367
[TBL] [Abstract][Full Text] [Related]
19. Cigarette smoke alters the invariant natural killer T cell function and may inhibit anti-tumor responses.
Hogan AE; Corrigan MA; O'Reilly V; Gaoatswe G; O'Connell J; Doherty DG; Lynch L; O'Shea D
Clin Immunol; 2011 Sep; 140(3):229-35. PubMed ID: 21684213
[TBL] [Abstract][Full Text] [Related]
20. Negative modulation of invariant natural killer T cell responses to glycolipid antigens by p38 MAP kinase.
Stuart JK; Bisch SP; Leon-Ponte M; Hayatsu J; Mazzuca DM; Maleki Vareki S; Haeryfar SM
Int Immunopharmacol; 2010 Sep; 10(9):1068-76. PubMed ID: 20584631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
